Clinical Performance and Safety of Suture-TOOL

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

38 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-01-10

Study Completion Date

2023-08-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this single arm intervention study is to investigate the safety and performance of a suturing device for closure of the midline incision after open abdominal surgery. The study population consists of 38 patients selected for open abdominal procedures for malignant and benign colorectal disease.

The main question it aims to answer is:

• If the device facilitates a Suture-Length to Wound-Length (SL/WL) ratio of 4:1

Participants laparotomy wound will be closed with the device at the end of the operation and closure related data as closure time and SL/WL ratio will be calculated. The wound will be assessed for infection during the postoperative stay and the chart will be reviewed for wound dehiscence and wound infection.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Suture Size in Laparotomy Wound Closure to Prevent Post-operative Complications

NCT05474677

Suture Size, Incisional Hernia

UNKNOWN NA

Comparing Wound Complications After Elective Abdominal Surgery Using Two Closure Techniques

NCT03527433

Wound Complication

RECRUITING NA

Subcuticular Suture Versus Staples for Closure of the Skin After Caesarean Section.

NCT01217567

Cesarean Section Cicatrix

COMPLETED NA

Abdominal Wall Closure With Triclosan-coated Suture

NCT01620294

Infection

COMPLETED PHASE3

Effect of Continuous Versus Interrupted Suturing on Wound Dehiscence and Infection After Abdominal Surgery

NCT07241507

Laparotomy Closure After Abdominal Surgery Wound Infection, Surgical Dehiscence of Laparotomy Wound +2 more

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Laparotomy Incisional Hernia Wound Infection Closure Technique

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Single arm prospective interventional study

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Single arm

Closure of the abdomen after laparotomy with Suture-TOOL.

Group Type EXPERIMENTAL

Suture-TOOL

Intervention Type DEVICE

Suture device for fast and standardized closure of the abdominal fascia

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Suture-TOOL

Suture device for fast and standardized closure of the abdominal fascia

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Informed consent: signed written informed consent before inclusion in the investigation
2. Sex, age: male and female patients, ≥ 18 years old
3. Surgery: elective open abdominal surgery for benign or malignant colorectal disease through midline incision.

Anticipated incision length ≥ 12 cm
4. Body Mass Index (BMI): 18 - 40 kg/m2 inclusive
5. Full comprehension: ability to comprehend the full nature and purpose of the investigation, including possible risks and side effects; ability to co-operate with the Investigator and to comply with the requirements of the entire investigation.

Exclusion Criteria

1. Abdominal Surgery: previous abdominal surgery involving the midline
2. Physical findings: clinically significant abnormal physical findings which could interfere with the objectives of the investigation according to the Investigator's opinion; existing midline hernia, cutaneous infection, fistula, psoriasis of abdominal skin; morbidly obese patients
3. Pre-operative findings: any pre-operative findings identified by the surgeon/Investigator that may preclude the conduct of the investigation procedures
4. Allergy: history of anaphylaxis to drugs or allergic reactions in general, which the Investigator considers could affect the outcome of the investigation
5. Diseases: known or identified at surgery disseminated cancer disease; collagen diseases and immune deficiency disorders, according to the Investigator's opinion. Significant history of renal, hepatic, gastrointestinal, cardiovascular, respiratory, skin, haematological, endocrine or neurological diseases that according to the Investigator's opinion may interfere with the aim of the investigation
6. Life expectancy: life expectancy less than 1 year
7. Medications: any medication that could interfere with the investigation procedures or investigation outcome, according to the Investigator's opinion. Hormonal contraceptives for women are allowed
8. Pregnancy and lactation: positive pregnancy test at screening (if applicable); pregnant or breastfeeding women
9. Vulnerable subjects: Individuals unable to fully understand all aspects of the investigation that are relevant to the decision to participate, or who could be manipulated or unduly influenced because of a compromised position, expectation of benefits or fear of retaliatory response (ISO 14155:2020 §3.55) will be excluded

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No